Tradestie Institutional Equity Comparison Engine

LMRI vs BUDA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

LMRI Overall Edge

LMRI Captures Institutional Edge (1โ€“0 Pillars ยท 1โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to LMRI (LMRI) driven by superior Momentum & Technical. Fundamentally, LMRI trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus BUDA at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, LMRI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BUDA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
LMRI N/M vs BUDA N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner LMRI
1Y -23.0% vs -34.6% ยท 52W Pos 60% vs 1%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
LMRI US Equity
LMRI
Institutional Equity
$14.26
+1.42% 1D
Market Cap N/A
1M Return +30.95%
1Y Return -23.0%
Forward P/E N/M
Unified AI Score
32.1 / 100 SELL
Tech 50.0 Fund 30.0 Flow 50.0 Mom 50.0
BUDA US Equity
BUDA
Institutional Equity
$5.30
-0.19% 1D
Market Cap N/A
1M Return -20.9%
1Y Return -34.65%
Forward P/E N/M
Unified AI Score
34.2 / 100 SELL
Tech 35.0 Fund 42.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: LMRI -23.0% BUDA -34.65% Spread: +15.08 pp (LMRI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
LMRI TTM Op. Margin: N/A BUDA TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LMRI vs BUDA. Trailing 12-month operating profitability (LMRI N/A vs BUDA N/A) and valuation multiples (LMRI N/M vs BUDA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: LMRI (1) vs BUDA (2)
Institutional Metric LMRI BUDA Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 60% ($6โ€“$19) 1% ($5โ€“$12) Stronger Trend LMRI
Beta / 30D Volatility Risk Regime 1.22ฮฒ ยท 85% Vol -0.03ฮฒ ยท 71% Vol Lower Realized Risk BUDA
Unified Institutional Score Composite Signal 32.1 / 100 (SELL) 34.2 / 100 (SELL) Higher Composite BUDA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full LMRI vs BUDA Buy Guide
LMRI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live LMRI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BUDA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BUDA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither LMRI nor BUDA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.